Market Cap 508.76M
Revenue (ttm) 31.08M
Net Income (ttm) -200.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -644.79%
Debt to Equity Ratio 0.47
Volume 1,144,676
Avg Vol 2,341,172
Day's Range N/A - N/A
Shares Out 363.40M
Stochastic %K 52%
Beta 0.96
Analysts Sell
Price Target $2.88

Company Profile

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. Its...

Industry: Biotechnology
Sector: Healthcare
Phone: 281 863 3000
Fax: 281 863 8088
Address:
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, United States
Beebomb
Beebomb Dec. 5 at 6:45 PM
$LXRX As a long-time bag holder who has run through nearly a lifetime of patience, I feel comfortable in saying acquisition is not in the cards for another couple of years. Only when all the current potentials have been confirmed will any buyer pay a price that meets the suspected minimum required by the controlling shareholder. Let a fistful of the known catalysts come to pass. Then, maybe then, there will be something to talk about.
0 · Reply
Badstick
Badstick Dec. 5 at 6:37 PM
$LXRX Loading….
0 · Reply
Slimben
Slimben Dec. 5 at 6:24 PM
$LXRX I was just about to post this, but I see some other guys are on the same wavelength. There has been no PR since November 10. An acquisition or merger must require a 30 day silent period. My Spidey sense says something’s up.
2 · Reply
KurwaMac
KurwaMac Dec. 5 at 5:29 PM
$LXRX this thing is coiling into a bullish flag, if you believe such magic
0 · Reply
TH3_PR0F1T
TH3_PR0F1T Dec. 5 at 4:30 PM
$LXRX My guess is they are finalizing a deal.
2 · Reply
JanetBSmellin
JanetBSmellin Dec. 5 at 4:24 PM
$LXRX Sorry, I bought more at $1.40 so it dropped immediately. 😵‍💫
0 · Reply
Dooright
Dooright Dec. 5 at 4:15 PM
$LXRX It takes buyer’s and seller’s to make a market. What I want to know is: why do we have more sellers than buyers at this point and who the fuck in their right mind would be selling now? SMH! 😖 Doc C. 🤓
2 · Reply
ThunderCoopersmith
ThunderCoopersmith Dec. 5 at 4:03 PM
$LXRX why no announcements? Things that make you go hmmmmmm 🤔
1 · Reply
epk1970
epk1970 Dec. 5 at 3:42 PM
0 · Reply
Rafrica
Rafrica Dec. 5 at 2:38 PM
$LXRX Lexicon to Present Sotagliflozin HFpEF Adipose Data at CVCT 2025 | LXRX Stock News https://share.google/3tdVCo85E5FnsmjQC
0 · Reply
Latest News on LXRX
Lexicon Pharmaceuticals: A Lottery Ticket With 3 Chances To Win

Nov 15, 2025, 6:46 AM EST - 20 days ago

Lexicon Pharmaceuticals: A Lottery Ticket With 3 Chances To Win


Lexicon (LXRX) Q2 Revenue Soars 1,706%

Aug 6, 2025, 4:50 PM EDT - 4 months ago

Lexicon (LXRX) Q2 Revenue Soars 1,706%


Top 2 Health Care Stocks That May Crash This Month

Apr 25, 2025, 9:00 AM EDT - 8 months ago

Top 2 Health Care Stocks That May Crash This Month


Lexicon Appoints Scott Coiante as Chief Financial Officer

Jan 2, 2025, 8:00 AM EST - 1 year ago

Lexicon Appoints Scott Coiante as Chief Financial Officer


Beebomb
Beebomb Dec. 5 at 6:45 PM
$LXRX As a long-time bag holder who has run through nearly a lifetime of patience, I feel comfortable in saying acquisition is not in the cards for another couple of years. Only when all the current potentials have been confirmed will any buyer pay a price that meets the suspected minimum required by the controlling shareholder. Let a fistful of the known catalysts come to pass. Then, maybe then, there will be something to talk about.
0 · Reply
Badstick
Badstick Dec. 5 at 6:37 PM
$LXRX Loading….
0 · Reply
Slimben
Slimben Dec. 5 at 6:24 PM
$LXRX I was just about to post this, but I see some other guys are on the same wavelength. There has been no PR since November 10. An acquisition or merger must require a 30 day silent period. My Spidey sense says something’s up.
2 · Reply
KurwaMac
KurwaMac Dec. 5 at 5:29 PM
$LXRX this thing is coiling into a bullish flag, if you believe such magic
0 · Reply
TH3_PR0F1T
TH3_PR0F1T Dec. 5 at 4:30 PM
$LXRX My guess is they are finalizing a deal.
2 · Reply
JanetBSmellin
JanetBSmellin Dec. 5 at 4:24 PM
$LXRX Sorry, I bought more at $1.40 so it dropped immediately. 😵‍💫
0 · Reply
Dooright
Dooright Dec. 5 at 4:15 PM
$LXRX It takes buyer’s and seller’s to make a market. What I want to know is: why do we have more sellers than buyers at this point and who the fuck in their right mind would be selling now? SMH! 😖 Doc C. 🤓
2 · Reply
ThunderCoopersmith
ThunderCoopersmith Dec. 5 at 4:03 PM
$LXRX why no announcements? Things that make you go hmmmmmm 🤔
1 · Reply
epk1970
epk1970 Dec. 5 at 3:42 PM
0 · Reply
Rafrica
Rafrica Dec. 5 at 2:38 PM
$LXRX Lexicon to Present Sotagliflozin HFpEF Adipose Data at CVCT 2025 | LXRX Stock News https://share.google/3tdVCo85E5FnsmjQC
0 · Reply
BullriderNkg
BullriderNkg Dec. 5 at 1:52 PM
$LXRX Perhaps as some Superior Cardiologists hear more about Sotagliflozin/Inpefa they will prescribe Inpefa for their patients. Yes, I know not likely to be significant for sales.
2 · Reply
stefano62
stefano62 Dec. 5 at 1:48 PM
$LXRX they are continuing to publish data on drugs, partecipate to conferences, but no actual fact that can rise Share price.... We need fact like FDA greenligth for zynquista, or outlook of the meeting to define the protocol for the phase 3 study of PILAVAPADIN or partnership for PILAVAPADIN....
1 · Reply
Pit1908
Pit1908 Dec. 5 at 1:47 PM
$LXRX +$6 🎁🎄📈💯
0 · Reply
Jbjb90
Jbjb90 Dec. 5 at 1:36 PM
$LXRX https://lexiconpharma.gcs-web.com/news-releases/news-release-details/clinical-data-effect-sotagliflozin-adipose-distribution-non
0 · Reply
Pit1908
Pit1908 Dec. 5 at 1:35 PM
$LXRX MONDAY +$6 🎁🎄📈💪🏻
1 · Reply
epk1970
epk1970 Dec. 4 at 11:32 PM
0 · Reply
Iman133
Iman133 Dec. 4 at 4:36 PM
$LXRX Hopefully, one day they will participate in such an event and will say: “thanks for your interest, but we are only here to say we don’t need any investors, as XXX has already acquired lexi to become sexy”
0 · Reply
macrossluvsrobotech
macrossluvsrobotech Dec. 4 at 4:09 PM
$LXRX Todavia sigues por aqui?
0 · Reply
Kabita84
Kabita84 Dec. 4 at 3:26 PM
$LXRX people made tons of money in capricor theraputic..here is waste of time..
3 · Reply
Kabita84
Kabita84 Dec. 4 at 3:25 PM
$LXRX guys how r u??.
0 · Reply
Dooright
Dooright Dec. 4 at 3:17 PM
$LXRX Most intriguing to me is that we are going to meet with the FDA this month regarding the design of the Phase 3 trial for Pilavapadin to begin in early 2006 and that we believe this trial will be best served with a partner. To me, the implication of that is that a partner will be announced imminently and that would of course include the terms and conditions of that partnership. Exciting times indeed. 😊 Doc C. 🤓
1 · Reply
blaack_rules
blaack_rules Dec. 4 at 2:53 PM
$LXRX A bit more detail on the FDA decision on Zynquista and some details about the 9211 phase 2 trials and the need and role for a partner. Notably absent, Exton.
3 · Reply